Healthcare provider profile · identity verified

Mark Lussier, M.D.

Family Practice · FAIRCHILD AFB, WA · NPI 1528356698

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	659	190
Lisinopril	Lisinopril	450	146
Amlodipine Besylate	Amlodipine Besylate	345	110
Losartan Potassium	Losartan Potassium	323	109
Levothyroxine Sodium	Levothyroxine Sodium	317	83
Tamsulosin Hcl	Tamsulosin Hcl	280	101
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	239	93
Trazodone Hcl	Trazodone Hcl	225	80
Pradaxa	Dabigatran Etexilate Mesylate	201	58
Simvastatin	Simvastatin	199	57
Metoprolol Tartrate	Metoprolol Tartrate	197	66
Pantoprazole Sodium	Pantoprazole Sodium	197	72
Hydrochlorothiazide	Hydrochlorothiazide	193	69
Gabapentin	Gabapentin	186	57
Metformin Hcl Er	Metformin Hcl	159	51
Sertraline Hcl	Sertraline Hcl	157	44
Albuterol Sulfate Hfa	Albuterol Sulfate	156	56
Metformin Hcl	Metformin Hcl	154	53
Metoprolol Succinate	Metoprolol Succinate	147	47
Potassium Chloride	Potassium Chloride	145	43
Atenolol	Atenolol	136	38
Glipizide	Glipizide	127	43
Rosuvastatin Calcium	Rosuvastatin Calcium	123	37
Oxycodone Hcl	Oxycodone Hcl	101	44
Omeprazole	Omeprazole	98	33
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	95	32
Pravastatin Sodium	Pravastatin Sodium	91	29
Meloxicam	Meloxicam	85	33
Spiriva Respimat	Tiotropium Bromide	83	26
Jardiance	Empagliflozin	78	23
Furosemide	Furosemide	76	30
Finasteride	Finasteride	75	28
Buspirone Hcl	Buspirone Hcl	74	22
Fluoxetine Hcl	Fluoxetine Hcl	72	22
Alendronate Sodium	Alendronate Sodium	71	25
Humulin N	Insulin Nph Human Isophane	69	22
Duloxetine Hcl	Duloxetine Hcl	65	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	65	21
Famotidine	Famotidine	62	17
Bupropion Xl	Bupropion Hcl	61	23
Triamcinolone Acetonide	Triamcinolone Acetonide	59	28
Clopidogrel	Clopidogrel Bisulfate	57	21
Spironolactone	Spironolactone	57	22
Allopurinol	Allopurinol	53	19
Methocarbamol	Methocarbamol	51	19
Terazosin Hcl	Terazosin Hcl	51	13
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	50	20
Prednisone	Prednisone	50	37
Lovastatin	Lovastatin	49	11
Lorazepam	Lorazepam	48	19
Carvedilol	Carvedilol	47	17
Isosorbide Mononitrate Er	Isosorbide Mononitrate	47	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	47	15
Warfarin Sodium	Warfarin Sodium	47	14
Valacyclovir	Valacyclovir Hcl	45	15
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	45	14
Estradiol	Estradiol	44	18
Montelukast Sodium	Montelukast Sodium	44	15
Alvesco	Ciclesonide	43	17
Citalopram Hbr	Citalopram Hydrobromide	43	15
Ondansetron Odt	Ondansetron	43	17
Wixela Inhub	Fluticasone Propion/Salmeterol	42	17
Mirtazapine	Mirtazapine	41	17
Venlafaxine Hcl Er	Venlafaxine Hcl	41	13
Bupropion Hcl Sr	Bupropion Hcl	40	13
Nystatin	Nystatin	38	16
Fluticasone Propionate	Fluticasone Propionate	37	11
Azelastine Hcl	Azelastine Hcl	36	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	35	11
Acyclovir	Acyclovir	34	14
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	34	12
Ropinirole Hcl	Ropinirole Hcl	32	suppressed
Tizanidine Hcl	Tizanidine Hcl	29	13
Veo Insulin Syringe	Syring-Needl,disp,insul,0.3 Ml	29	suppressed
Chlorthalidone	Chlorthalidone	28	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	28	suppressed
Hydrocortisone	Hydrocortisone	27	suppressed
Donepezil Hcl	Donepezil Hcl	26	suppressed
Nitroglycerin	Nitroglycerin	26	17
Shingrix	Varicella-Zoster Ge/As01b/Pf	26	23
Tramadol Hcl	Tramadol Hcl	26	19
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	26	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	26	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	25	11
Escitalopram Oxalate	Escitalopram Oxalate	24	11
Humulin R	Insulin Regular, Human	24	suppressed
Propranolol Hcl	Propranolol Hcl	24	suppressed
Xarelto	Rivaroxaban	24	suppressed
Eliquis	Apixaban	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	22	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	22	suppressed
Lactulose	Lactulose	22	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	21	20
Nortriptyline Hcl	Nortriptyline Hcl	21	suppressed
Pregabalin	Pregabalin	20	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	19	suppressed
Torsemide	Torsemide	19	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	18	suppressed
Rizatriptan	Rizatriptan Benzoate	18	suppressed
Valsartan	Valsartan	18	suppressed
Amoxicillin	Amoxicillin	17	12
Doxepin Hcl	Doxepin Hcl	17	suppressed
Cephalexin	Cephalexin	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Alprazolam	Alprazolam	15	suppressed
Clonazepam	Clonazepam	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	15	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	14	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	14	suppressed
Tenivac	Tetanus-Diphtheria Toxoids/Pf	14	14
Digoxin	Digoxin	13	suppressed
Ropinirole Er	Ropinirole Hcl	13	suppressed
Breyna	Budesonide/Formoterol Fumarate	12	suppressed
Bupropion Hcl	Bupropion Hcl	12	suppressed
Latanoprost	Latanoprost	12	suppressed
Morphine Sulfate	Morphine Sulfate	12	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	12	suppressed
Ozempic	Semaglutide	12	suppressed
Atropine Sulfate	Atropine Sulfate	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Mometasone Furoate	Mometasone Furoate	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	11
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Testosterone	Testosterone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error